Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026)
Artivion (AORT) reported Liabilities and Shareholders Equity of $883.2 million for Q1 2026, up 11.63% on a YoY basis from $791.2 million in Q1 2025, and little changed quarter-over-quarter from $884.8 million in Q4 2025.
Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Artivion has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $883.2 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 11.63% year-over-year to $883.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 billion (up 9.17% YoY), and the FY2025 full-year result was $884.8 million, up 12.13% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $883.2 million, roughly flat from $884.8 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $884.8 million in Q4 2025, with the low at $742.7 million in Q3 2022.
- Historically, Liabilities and Shareholders Equity has averaged $798.5 million across 5 years, with a median of $789.1 million in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 9.27% — and 2025, when it climbed 12.13%.
- Artivion's Liabilities and Shareholders Equity stood at $762.8 million in 2022, then rose by 3.88% to $792.4 million in 2023, then slipped by 0.42% to $789.1 million in 2024, then rose by 12.13% to $884.8 million in 2025, then retreated by 0.19% to $883.2 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $883.2 million (Q1 2026), $884.8 million (Q4 2025), and $857.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Artivion | 978.31 Mn | 922.54 Mn | 75.45 Mn | 883.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 883.16 Mn |
| Dec 31, 2025 | 884.80 Mn |
| Sep 30, 2025 | 857.66 Mn |
| Jun 30, 2025 | 838.39 Mn |
| Mar 31, 2025 | 791.16 Mn |
| Dec 31, 2024 | 789.10 Mn |
| Sep 30, 2024 | 803.14 Mn |
| Jun 30, 2024 | 789.54 Mn |
| Mar 31, 2024 | 784.01 Mn |
| Dec 31, 2023 | 792.40 Mn |
| Sep 30, 2023 | 774.79 Mn |
| Jun 30, 2023 | 777.86 Mn |
| Mar 31, 2023 | 757.07 Mn |
| Dec 31, 2022 | 762.80 Mn |
| Sep 30, 2022 | 742.73 Mn |
| Jun 30, 2022 | 764.86 Mn |
| Mar 31, 2022 | 781.86 Mn |
| Dec 31, 2021 | 793.05 Mn |
| Sep 30, 2021 | 818.65 Mn |
| Jun 30, 2021 | 810.50 Mn |